country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

Art. -Nr.: HY-P11113

Copy Link Print Information

PFVYLI

PFVYLI is a hydrophobic penetrating peptide that can be used to modify doxorubicin-loaded stealth persistent liposomes (PFV-ssls-dox) for breast cancer research.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

CAS. Nr.: 1252672-28-8
Formel: C₄₀H₅₈N₆O₈
Molecular Weight:750.92

Speicherung:

Please store the product under the recommended conditions in the Certificate of Analysis.

PFVYLI Chemical Structure

CAS. Nr.: 1252672-28-8

Größe

Preis

Verfügbarkeit

Menge

Amount: USD 0.00

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

Use of MCE Products

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

Biologische Aktivität
- Beschreibung
- Cellular Effect
Chemical Information
Reinheit & Dokumentation
Verweise
Calculators
Help & FAQs
Classifications
Bioz

Biologische Aktivität

Beschreibung

PFVYLI is a hydrophobic penetrating peptide that can be used to modify doxorubicin-loaded stealth persistent liposomes (PFV-ssls-dox) for breast cancer research^[1].

Cellular Effect

Cell Line	Type	Value	Description	References
MT2	IC₅₀	>100 μM Compound: PI6	Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of viral replication after 4 days by ELISA Antiviral activity against Human immunodeficiency virus 1 3B infected in human MT2 cells assessed as inhibition of viral replication after 4 days by ELISA	[PMID: 22406118]

Chemical Information

CAS. Nr. 1252672-28-8
Molecular Weight 750.92
Formel C₄₀H₅₈N₆O₈
Sequence

Pro-Phe-Val-Tyr-Leu-Ile
Sequence Shortening

PFVYLI
Versand

Room temperature in continental US; may vary elsewhere.
Speicherung

Please store the product under the recommended conditions in the Certificate of Analysis.

Reinheit & Dokumentation

Select Batch:

Reinheit: 99.98%

Assay: 99.98%

ee.: 99.98%

Data Sheet (267 KB)
COA (2659 KB)
Elemental Analysis Report (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
Handling Instructions (2659 KB)

Verweise

[1]. Cai D, et al. Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy. Biomaterials. 2014 Feb;35(7):2283-94. [Content Brief]

Calculators

Molaritätsrechner

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

Konzentration Konzentration

Volumen Volumen

Molecular Weight Molecular Weight

Verdünnungsrechner

Konzentration _{(Stammlösung)} × Volumen _{(Stammlösung)} = Konzentration _{(Ziellösung)} × Volumen _{(Ziellösung)}

Konzentration _{(Stammlösung)} Konzentration _{(Stammlösung)}

Volumen _{(Stammlösung)} Volumen _{(Stammlösung)}

Konzentration _{(Ziellösung)} Konzentration _{(Ziellösung)}

Volumen _{(Ziellösung)} Volumen _{(Ziellösung)}

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Bioz

Keywords

MOQ

Minimum order quantity

100 mg

Angebot einholen Auf Lager

Other size

Angebot einholen